Insider · CIK 0001816206
Timothy Van Hauwermeiren
Files at DNLI (Denali Therapeutics Inc.), ITOS (iTeos Therapeutics, Inc.), LXEO (Lexeo Therapeutics, Inc.). First filing -, latest -.
Timothy Van Hauwermeiren files SEC Form 4 as director at DNLI (Denali Therapeutics Inc.), and also at ITOS (iTeos Therapeutics, Inc.), LXEO (Lexeo Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Timothy Van Hauwermeiren has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | DNLI Denali Therapeutics Inc. | AGrant or award Common Stock | +6,408 | $0.00 | $0 | 17,040 | Jun 5, 2026 |
| Jun 3, 2026 | DNLI Denali Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +19,226 | $0.00 | $0 | 19,226 | Jun 5, 2026 |
| Nov 4, 2025 | DNLI Denali Therapeutics Inc. | AGrant or award Common Stock | +10,632 | $0.00 | $0 | 10,632 | Nov 6, 2025 |
| Nov 4, 2025 | DNLI Denali Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +31,897 | $0.00 | $0 | 31,897 | Nov 6, 2025 |
| Jun 26, 2025 | LXEO Lexeo Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +22,916 | $0.00 | $0 | 22,916 | Jun 30, 2025 |
| May 13, 2025 | ITOS iTeos Therapeutics, Inc. | MOption exercise Common Stock | +22,346 | $4.30 | $96k | 22,346 | May 14, 2025 |
| May 13, 2025 | ITOS iTeos Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -22,346 | $0.00 | $0 | 0 | May 14, 2025 |
Questions about Timothy Van Hauwermeiren
Answered from the filings on this page, as of the latest one.
Is Timothy Van Hauwermeiren buying or selling?
Timothy Van Hauwermeiren has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Timothy Van Hauwermeiren's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Timothy Van Hauwermeiren has 0.
Where does Timothy Van Hauwermeiren file Form 4?
Timothy Van Hauwermeiren has filed Form 4 at DNLI (Denali Therapeutics Inc.); ITOS (iTeos Therapeutics, Inc.); LXEO (Lexeo Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.